The microbial metabolite indole was shown to alleviate the severity of HFD- or MCD-induced NAFLD by inhibiting macrophage activation in a PFKFB3-dependent manner (Ma et al., 2020; Zhu B. et al., 2022). This evidence concerns the gene PFKFB3 and metabolic dysfunction-associated steatotic liver disease.